Spain Scrutinizes Menopause Guidelines After Critics Note Male-Only Data Basis
Spain’s food safety agency is reviewing menopause nutrition guidelines after critics noted the advice relied exclusively on male study data. The document, released in March 2026, recommended protein, calcium, and strength training to address bone and muscle loss but failed to warn that the underlying European Food Safety Authority studies involved only men. Female scientists and the Minister for Equality have called for a formal review, highlighting how male-centric research ignores distinct female hormonal and nutritional needs, such as higher calcium and iron requirements for post-menopausal women.
Key points
- The Spanish Agency for Food Safety and Nutrition (AESAN) published menopause nutrition guidelines in March 2026 based solely on male population data.
- The guidelines recommended diets rich in protein, iron, calcium, omega-3, and vitamins, along with strength training, to mitigate bone density and muscle loss.
- The AESAN did not explicitly warn consumers that the reference studies excluded women, an omission criticized by the Spanish Association of Women Researchers and Technologists (AMIT).
- AESAN acknowledged the 'omission of a warning' and has ordered a formal review by its scientific committee.
- Spanish Minister for Equality Ana Redondo called for a review, stating that the male body should no longer be the universal reference point for health issues affecting women.
- Nutritional needs differ significantly; for example, women over 50 require 1,200 mg of calcium versus 1,000 mg for men, and 18 mg of iron versus 8 mg for men.
Background
This incident reflects broader concerns about the historical underrepresentation of women in medical research and clinical trials. While previous discussions have focused on specific nutrient recommendations, such as protein intake for aging or potassium for blood pressure, the core issue here is the foundational bias in using male physiology as the default standard for conditions unique to women, such as menopause. This oversight highlights the gap between general nutritional advice and the specific hormonal and biological changes women experience during perimenopause and post-menopause.
Why it matters
The controversy underscores the critical need for sex-specific data in medical guidelines. Relying on male-only studies can lead to inaccurate nutritional recommendations for women, potentially affecting bone health, muscle mass, and overall well-being during menopause. It also signals a growing push for greater female representation in clinical trials and health policy to ensure that medical advice is tailored to the biological realities of all patients.
What to watch
The AESAN is conducting a formal review of the guidelines by its scientific committee. The outcome may lead to revised recommendations that incorporate data from female populations or explicitly state the limitations of the current evidence. This review could set a precedent for how other agencies handle gender-specific health issues and ensure that future guidelines are inclusive and accurate.
Want the full story? Read the original reporting
Read on New York Post